|
591 |
Understanding disease and illness Enthalten in Theoretical medicine and bioethics Bd. 38, 13.7.2017, Nr. 4, date:8.2017: 239-244
|
|
|
592 |
Understanding the null hypothesis (H0) in non-inferiority trials Enthalten in Critical care Bd. 21, 6.5.2017, Nr. 1, date:12.2017: 1-2
|
|
|
593 |
Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes Enthalten in Diabetologia Bd. 60, 10.6.2017, Nr. 9, date:9.2017: 1782-1790
|
|
|
594 |
US FDA requests hold on early clinical trials of atezolizumab Enthalten in Reactions weekly Bd. 1671, 30.9.2017, Nr. 1, date:9.2017: 6
|
|
|
595 |
Use and Safety of Anthroposophic Medicinal Products: An Analysis of 44,662 Patients from the EvaMed Pharmacovigilance Network Enthalten in Drugs - real world outcomes Bd. 4, 30.9.2017, Nr. 4, date:12.2017: 199-213
|
|
|
596 |
Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: A descriptive study Enthalten in BMC complementary and alternative medicine Bd. 17, 4.5.2017, Nr. 1, date:12.2017: 1-10
|
|
|
597 |
Using regulatory enforcement theory to explain compliance with quality and patient safety regulations: the case of internal audits Enthalten in BMC health services research Bd. 18, 30.1.2018, Nr. 1, date:12.2018: 1-6
|
|
|
598 |
Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access Enthalten in Trials Bd. 18, 23.8.2017, Nr. 1, date:12.2017: 1-11
|
|
|
599 |
Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol Enthalten in Pilot and feasibility studies Bd. 4, 18.7.2017, Nr. 1, date:12.2018: 1-9
|
|
|
600 |
Validation of the AUDIT-C in adults seeking help with their drinking online Enthalten in Addiction science & clinical practice Bd. 12, 4.1.2017, Nr. 1, date:12.2017: 1-11
|
|